Breath-Actuated Metered Dose Inhaler
Inhalers, Breath Actuated Inhalers
Pharma
Aptar Pharma’s Breath Actuated Inhaler (BAI), is used in conjunction with a pressurized metered dose inhaler (pMDI) to automatically trigger the inhaler spray actuation when the patient is breathing in. This can greatly reduce patient coordination errors and improve their compliance for all patients with asthma and COPD.
Our BAI metered dose inhaler can also integrate a dose counting function to remind patients of the number of doses remaining for chronic respiratory conditions like asthma and COPD.
Download Aptar Pharma Overview Brochure
Breath-Actuated Inhaler Improves Patient Compliance in Asthma and COPD
Patient Focused Design
Aptar Pharma developed the Breath-actuated inhaler to make respiratory drug delivery simpler for patients with asthma and COPD . The device is small, lightweight and portable and virtually eliminates the patient coordination errors sometimes seen with traditional pressurized metered dose inhaler (pMDI) devices.
Enhanced Patient Compliance
Our Breath Actuated Inhaler (BAI) coordinates the release of the drug product from the metering valve, which helps to overcome patient coordination techniques and the need for inspiration (flow) rates. Aptar Pharma’s BAIs are designed with the patient in mind.
Lifecycle Management Opportunities
Utilizing Aptar Pharma’s proprietary Breath Actuated metered dose Inhaler (BAI) opens numerous lifecycle management opportunities and can support brand differentiation strategies.
Integrated Development and Support Services for OINDP
Aptar Pharma offers fully integrated development and support services including product design and method validation, analysis of drug device interactions, analytical testing, formulation development as well as regulatory support to help advance your Breath-actuated inhaler product more efficiently.
Designed with patients in mind
Aptar Pharma’s dedicated R&D teams designed the Breath-Actuated Inhaler to make the inhalation process easier for patients suffering from asthma or COPD. Patient compliance is critical for these chronic diseases in order to manage their care. Our BAI is simple to use for patients of all ages, including children and the elderly. It is small, lightweight, and can easily be carried in a purse, pocket or bag for portability.
Patients simply place the mouthpiece in their mouth and breathe in. The BAI senses the inhalation and automatically coordinates the actuation of the metering valve to release the product spray. This means the patient does not have to even think about coordinating inhalation with actuation, like they would with conventional pMDI inhaler systems. Some patients with low inspiration rates (flow rates) can benefit from Breath Actuated Inhalers as they ensure higher levels of dose consistency.
Enhances Patient Compliance
A breath-actuated inhaler can enhance patient compliance as it makes the drug delivery process simple and essentially eliminates coordination errors. Our BAI coordinates the release of the drug product from the metering valve, which helps to overcome patient coordination errors and the need for high inspiration (flow) rates. By minimizing patient errors via this technology, the BAI delivers higher patient compliance and adherence. Aptar Pharma’s Breath Actuated Inhalers are designed with the patient user in mind. They are small, lightweight, and portable, capable of fitting in purses, pockets, or bags so they are ideal for staying with the patient. Always ready when needed.
In addition, our BAI devices include an integrated dose counting mechanism so the patient can always have confidence in the number of doses remaining and help track doses taken. Aptar Pharma matches the metering valve with both the BAI triggering and dose-counting mechanisms resulting in a fully integrated and intuitive solution that is easy to use by patients.
Lifecycle Management Opportunities
Utilizing Aptar Pharma’s BAI opens numerous lifecycle management opportunities and can support brand differentiation strategies. Our proprietary Breath-Actuated Inhaler technology provides many functional advantages for your inhaler product. We can integrate our BAI, optimized metering valves, and digital dose counter in one single device that comes in a range of color options, which open a world of product differentiation opportunities. Whether it’s a new inhalation product or a repositioned drug product, Aptar Pharma’s Breath-actuated inhaler can prove a viable option for inhalation products.
Integrated Support and Development Services
Aptar Pharma’s BAI is our fully integrated pressurized metered dose inhaler (pMDI) inhalation system that enhances patient compliance. We also offer fully integrated support and development services including analytical and formulation development as well as regulatory support to help bring customer inhalation products to market sooner and more efficiently. We add value at every stage of the drug-development process, accelerating and reducing the risk of programs along the way with our experience and specialized expertise.
Breath Actuated Inhaler Advantages
- Simple to Use
- Enhanced Patient Compliance
- A Life Cycle Management Solution
- A Complete Metered Dose Inhaler Solution
- Convenient and portable
Our Breath Actuated Inhaler eliminates patient coordination errors
Simply place the mouthpiece in the mouth and breathe in. It’s that simple. And the result is ease of use and peace of mind for the patient.
Our Breath-Actuated Inhaler incorporates breath triggering function and dose counting
Our BAI integrates Breath Actuating technology in the same device as reliable dose counting features (Choice of mechanical or digital dose-display counters) to enhance patient compliance. Our patented breath-triggering actuation minimizes the risk of coordination errors while dose counting prompts patient adherence.
Our Breath-Actuated Inhaler extends the life of your product and offers opportunities to add value by differentiating and protecting your brand
Our unique patent protected BAI technology platform provides opportunities for product differentiation, to protect your brand and offers alternative solutions for generic pharmaceutical companies.
Our Breath-Actuated Inhaler integrates metering valves and dose counters in one device
All of the component options are designed to work together delivering the optimal user experience in convenience and compliance. Discover the BAI inhaler that matches your product and brand.
Our Breath-Actuated Inhaler is small, lightweight and portable
An intuitive, appealing product for day-to-day use, on the go. Ideal for chronic respiratory conditions such as asthma and COPD.
We Thrive On Helping You Transform Your Ideas Into Commercial Opportunities.
We can accelerate and reduce the risk of your inhalation drug-development project with our comprehensive range of value added services.
This Might Also Be of Interest
Interview with Guillaume Brouet on Aptar Pharma Services
Publications, Pharmaceutical, Innovation & Insights
Aptar Pharma provides guidance on FDA regulatory framework for OINDPs
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Connected Medicine: Insights from Payers and Other Stakeholders
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation
Connected Health – An Effective Solution to Improve Patient Adherence
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Product Solutions, Innovation & Insights
We Have a Broad Range of Value Added Services to Accelerate and Derisk Your Drug Product Development.
Start a Project With Us
We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.
We Offer World-Leading Support Services for You at Every Stage of Your Product Development
Explore How We Serve Your Market
Request More Information
Requesting information on Breath-Actuated Metered Dose Inhaler.
How Can We Help?
